thirtythre
sampl
either
nasal
swab
nasopharyng
aspir
collect
suspect
merscov
infect
patient
two
differ
site
riyadh
king
fahad
medic
citi
patholog
clinic
laboratori
medicin
administr
region
laboratori
riyadh
saudi
arabia
nucleic
acid
sampl
extract
use
magna
pure
lc
magna
pure
lc
total
nucleic
acid
isol
kit
extern
lysi
protocol
magna
pure
total
na
isol
kit
pathogen
univers
protocol
roch
life
scienc
usa
sampl
volum
elut
volum
accord
manufactur
manual
urinecerebrospin
fluidswab
sampl
volum
elut
volum
sampl
analyz
use
ceivd
mark
realstar
merscov
rtpcr
kit
altona
diagnost
gmbh
accord
manufactur
instruct
use
http
altonadiagnosticscomensupportdownloadshtml
instrument
ii
roch
accord
manufactur
manual
default
set
realstar
merscov
rtpcr
kit
compris
two
independ
detect
assay
one
target
region
upstream
e
gene
upe
target
open
read
frame
assay
contain
intern
control
ic
use
monitor
effici
nucleic
acid
extract
process
possibl
inhibitori
effect
rtpcr
sampl
test
site
store
reanalyz
retrospect
molecular
microbiolog
depart
patholog
clinic
laboratori
medicin
administr
purpos
valid
realstar
merscov
n
gene
rtpcr
kit
altona
diagnost
gmbh
confirmatori
assay
accord
diagnost
scheme
propos
figur
realstar
merscov
n
gene
rtpcr
kit
compris
n
gene
specif
detect
system
assay
characterist
analyt
perform
characterist
found
ifu
kit
http
altonadiagnosticscomensupportdownloadshtml
analyt
sensit
realstar
merscov
n
gene
rtpcr
kit
determin
probit
analysi
ci
ic
use
nucleic
acid
extract
control
andor
rtpcr
inhibit
control
part
kit
ic
heterolog
rtpcr
system
vitro
transcript
ivt
artifici
sequenc
target
molecul
ic
use
analyz
accord
ifu
kit
http
altonadiagnosticscomensupportdownloadshtml
absenc
crossreact
test
analyz
genom
dnarna
differ
organ
either
relat
merscov
show
preval
caus
similar
symptom
tabl
use
realstar
merscov
n
gene
rtpcr
kit
deep
well
rtpcr
detect
system
biorad
ca
usa
instrument
dnarna
pathogen
analyz
three
replic
total
number
suspect
merscov
specimen
collect
two
differ
laboratori
site
riyadh
saudi
arabia
sampl
analyz
use
realstar
merscov
rtpcr
kit
sampl
test
molecular
microbiolog
depart
patholog
clinic
laboratori
medicin
administr
tabl
sampl
number
ten
eleven
sampl
show
posit
signal
assay
eight
sampl
shown
accord
result
use
upe
assay
two
sampl
posit
one
assay
neg
definit
sampl
equivoc
uncertain
one
suspect
merscov
specimen
test
neg
merscov
rna
assay
tabl
sampl
analyz
region
laboratori
tabl
sampl
number
sampl
test
posit
target
test
posit
one
target
equivoc
definit
test
neg
merscov
rna
tabl
order
valid
realstar
merscov
n
gene
rtpcr
kit
sampl
eluat
retest
retrospect
molecular
microbiolog
depart
patholog
clinic
laboratori
medicin
administr
king
fahad
medic
citi
therefor
specimen
region
laboratori
transfer
king
fahad
medic
citi
patholog
clinic
laboratori
medicin
administr
sampl
test
posit
assay
realstar
merscov
rtpcr
kit
also
test
posit
realstar
merscov
n
gene
rtpcr
kit
sampl
test
neg
realstar
merscov
rtpcr
kit
also
test
neg
realstar
merscov
n
gene
rtpcr
kit
two
sampl
test
posit
one
assay
realstar
merscov
rtpcr
kit
molecular
microbiolog
depart
patholog
clinic
laboratori
medicin
administr
test
posit
realstar
merscov
n
gene
rtpcr
kit
two
sampl
test
posit
one
assay
realstar
merscov
rtpcr
kit
region
laboratori
test
neg
realstar
merscov
n
gene
rtpcr
kit
none
dnarna
differ
pathogen
tabl
either
relat
merscov
show
preval
caus
similar
symptom
merscov
test
posit
merscov
n
gene
show
excel
specif
realstar
merscov
n
gene
rtpcr
kit
sinc
discoveri
merscov
caus
confirm
case
countri
total
number
fatal
worldwid
first
known
case
intern
expert
team
work
togeth
order
investig
emerg
diseas
detail
develop
reliabl
diagnost
tool
protocol
use
contain
spread
viru
sequenc
data
gener
releas
enabl
develop
specif
molecular
diagnost
assay
detect
merscov
distinguish
relat
human
coronavirus
like
sar
viru
today
vaccin
specif
treatment
mer
avail
thu
earli
case
recognit
isol
infect
person
strategi
curb
spread
viru
sinc
viru
detect
shortli
onset
symptom
diagnost
cell
cultur
slow
practic
special
laboratori
specif
detect
merscov
rna
via
rtpcr
method
choic
recommend
illustr
figur
recommend
test
merscov
suspect
sampl
two
differ
genom
sequenc
exampl
region
upstream
e
gene
upe
open
read
frame
accord
recommend
suspect
merscov
sampl
consid
posit
confirm
two
independ
rtpcr
test
target
differ
genom
region
case
posit
pcr
result
singl
specif
target
without
test
histori
potenti
exposur
consid
probabl
case
suggest
cours
action
would
either
perform
anoth
pcr
sequenc
third
genom
region
figur
ideal
freshli
extract
rna
properli
store
specimen
falseneg
result
may
occur
due
poor
qualiti
specimen
collect
specimen
late
earli
diseas
inappropri
handl
shipment
specimen
due
technic
reason
inher
perform
test
viru
mutat
pcr
inhibit
proper
specimen
collect
transport
condit
extract
method
storag
eluat
major
impact
qualiti
rna
therefor
reliabl
molecular
diagnost
ceivd
mark
realstar
merscov
rtpcr
kit
compris
two
independ
assay
one
target
upe
target
use
two
differ
diagnost
laboratori
riyadh
saudi
arabia
test
merscov
suspect
sampl
sampl
could
diagnos
posit
n
neg
n
merscov
rna
four
sampl
test
molecular
microbiolog
depart
patholog
clinic
laboratori
medicin
administr
king
fahad
medic
citi
test
region
laboratori
came
equivoc
result
posit
one
two
assay
tabl
result
demonstr
equivoc
result
may
occur
occasion
differ
reason
equivoc
result
studi
sampl
equivoc
result
valid
ic
signal
rtpcr
inhibit
explan
neg
result
one
two
assay
exclud
differ
sensit
two
assay
might
anoth
reason
equivoc
result
analyt
sensit
two
assay
similar
four
equivoc
sampl
three
posit
assay
neg
upe
assay
one
sampl
vice
versa
also
speak
signific
differ
sensit
two
assay
case
equivoc
result
occur
sampl
viru
concentr
close
limit
detect
assay
lead
posit
neg
result
statist
manner
like
caus
equivoc
result
sampl
sampl
number
show
valid
ic
signal
assay
threshold
cycl
ct
valu
around
neg
result
upe
rel
low
ct
valu
posit
result
suggest
sampl
viru
concentr
well
limit
detect
assay
like
equivoc
result
therefor
issu
sensit
caus
mutat
within
upe
target
region
impair
upe
assay
perform
emerg
virus
limit
sequenc
inform
avail
dual
target
strategi
reduc
risk
falseneg
result
due
differ
target
sequenc
assay
differ
genotyp
especi
import
rna
virus
coronavirus
tend
high
mutat
rate
follow
recommend
diagnosi
merscov
confirmatori
assay
use
retest
equivoc
sampl
studi
use
newli
develop
realstar
merscov
n
gene
rtpcr
kit
reanalyz
sampl
posit
neg
equivoc
molecular
microbiolog
depart
king
fahad
medic
citi
purpos
eluat
sampl
initi
analyz
region
laboratori
transfer
molecular
microbiolog
depart
sampl
test
posit
assay
realstar
merscov
rtpcr
kit
also
test
posit
realstar
merscov
n
gene
rtpcr
kit
sampl
origin
test
neg
could
confirm
neg
realstar
merscov
n
gene
rtpcr
kit
sampl
number
test
neg
three
merscov
detect
assay
later
confirm
posit
influenzaa
rna
two
sampl
equivoc
result
test
molecular
microbiolog
depart
posit
n
gene
assay
therefor
sampl
consid
posit
merscov
specif
rna
differ
pictur
present
sampl
transfer
molecular
microbiolog
depart
patholog
clinic
laboratori
medicin
administr
two
equivoc
sampl
show
neg
result
realstar
merscov
n
gene
rtpcr
kit
even
though
ic
signal
valid
therefor
inhibit
rtpcr
observ
posit
signal
detect
specif
channel
therefor
accord
diagnost
protocol
recommend
sampl
consid
neg
merscov
sinc
sampl
store
year
transport
molecular
microbiolog
depart
recent
rna
decay
might
possibl
explan
absenc
detect
merscov
rna
two
sampl
sampl
one
posit
tabl
sampl
number
one
posit
upe
tabl
sampl
number
shown
similar
ct
valu
therefor
like
merscov
rna
concentr
limit
detect
two
assay
assay
target
n
gene
known
slightli
less
sensit
comparison
assay
target
upe
failur
specif
detect
due
sensit
assay
exclud
like
along
low
amount
merscov
rna
decreas
throughout
time
period
storag
andor
transfer
specimen
specimen
would
origin
patient
confirm
exposur
merscov
sampl
would
consid
probabl
case
reprocess
specimen
would
highli
recommend
specimen
retrospect
test
addit
specimen
taken
patient
result
studi
show
realstar
merscov
n
gene
rtpcr
kit
consid
suitabl
reliabl
confirmatori
assay
combin
realstar
merscov
rtpcr
kit
accord
diagnost
scheme
recommend
